| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,6 M € | +7.9% | 7,9 M € | +3.5% | 7,7 M € | +8.5% | 7,1 M € | +5.9% | 6,7 M € | +1.2% | 6,6 M € | -1.8% | 6,7 M € | +2.0% | 6,6 M € | +1.3% | 6,5 M € | +0.3% | 6,5 M € | -0.3% | 6,5 M € | -0.1% | 6,5 M € | +11.2% | 5,8 M € | +22.1% | 4,8 M € | +6.5% | 4,5 M € | +3.4% | 4,3 M € | +4.1% | 4,2 M € | +4.5% | 4,0 M € | +2.8% | 3,9 M € | |
| EBITDA | 3,2 M € | +139.7% | 1,3 M € | -39.8% | 2,2 M € | +0.8% | 2,2 M € | -4.8% | 2,3 M € | -3.3% | 2,4 M € | -2.5% | 2,5 M € | -12.2% | 2,8 M € | +4.7% | 2,7 M € | -5.5% | 2,8 M € | +5.8% | 2,7 M € | -2.0% | 2,7 M € | +81.6% | 1,5 M € | +10.2% | 1,4 M € | +4.9% | 1,3 M € | +7.8% | 1,2 M € | -8.3% | 1,3 M € | +9.2% | 1,2 M € | +11.4% | 1,1 M € | |
| Operating profit | 1,4 M € | +1125.6% | -139,8 k € | -113.4% | 1,0 M € | +9.3% | 955,4 k € | -9.8% | 1,1 M € | -3.8% | 1,1 M € | -7.0% | 1,2 M € | -25.6% | 1,6 M € | +8.0% | 1,5 M € | -8.7% | 1,6 M € | +14.0% | 1,4 M € | -3.7% | 1,5 M € | +383.8% | 303,7 k € | -40.1% | 506,6 k € | +11.8% | 453,1 k € | +8.4% | 418,0 k € | -37.1% | 664,3 k € | +21.3% | 547,5 k € | +25.3% | 436,9 k € | |
| Profit/loss | 508,0 k € | +163.7% | -797,3 k € | -215.1% | 692,5 k € | +42.5% | 485,9 k € | -30.0% | 693,8 k € | +6.9% | 649,3 k € | -44.7% | 1,2 M € | +18.7% | 988,4 k € | +9.0% | 906,9 k € | -9.7% | 1,0 M € | +34.6% | 746,6 k € | +20.0% | 622,1 k € | +286.8% | -333,1 k € | -553.8% | 73,4 k € | +132.1% | -228,5 k € | -383.1% | 80,7 k € | -64.5% | 227,1 k € | -23.0% | 294,9 k € | +63.5% | 180,4 k € | |
| Equity | 16,2 M € | +2.1% | 15,8 M € | -6.4% | 16,9 M € | +2.3% | 16,5 M € | +4.2% | 15,9 M € | +2.4% | 15,5 M € | +1.8% | 15,2 M € | +5.4% | 14,5 M € | +4.3% | 13,9 M € | +4.1% | 13,3 M € | +4.8% | 12,7 M € | +2.9% | 12,3 M € | +1.9% | 12,1 M € | -5.3% | 12,8 M € | +70.7% | 7,5 M € | +0.6% | 7,4 M € | -1.7% | 7,6 M € | +0.2% | 7,6 M € | +1.1% | 7,5 M € | |
| Total assets | 48,6 M € | +6.6% | 45,6 M € | +8.8% | 41,9 M € | +38.8% | 30,2 M € | +3.4% | 29,2 M € | -1.4% | 29,6 M € | -2.1% | 30,3 M € | -1.7% | 30,8 M € | +0.3% | 30,7 M € | -1.4% | 31,1 M € | -1.1% | 31,4 M € | -3.1% | 32,4 M € | -2.2% | 33,2 M € | +6.3% | 31,2 M € | +53.8% | 20,3 M € | +1.6% | 20,0 M € | -2.7% | 20,5 M € | +29.5% | 15,8 M € | +2.3% | 15,5 M € | |
| Cash | 277,6 k € | +755.4% | 32,4 k € | -97.9% | 1,5 M € | -27.7% | 2,1 M € | -22.5% | 2,7 M € | +22.6% | 2,2 M € | +23.0% | 1,8 M € | +23.3% | 1,5 M € | +81.9% | 810,1 k € | -40.3% | 1,4 M € | +112.7% | 638,3 k € | +876.7% | 65,4 k € | +80.7% | 36,2 k € | -91.4% | 419,9 k € | +82.7% | 229,8 k € | +2005.1% | 10,9 k € | -99.4% | 1,8 M € | +955.8% | 166,7 k € | -27.5% | 229,9 k € | |
| Debts | 32,3 M € | +9.1% | 29,6 M € | +19.2% | 24,8 M € | +84.2% | 13,5 M € | +2.4% | 13,2 M € | -5.4% | 13,9 M € | -6.1% | 14,8 M € | -8.0% | 16,1 M € | -2.8% | 16,6 M € | -5.4% | 17,5 M € | -4.8% | 18,4 M € | -7.1% | 19,8 M € | -5.2% | 20,9 M € | +14.2% | 18,3 M € | +43.6% | 12,7 M € | +2.3% | 12,4 M € | -3.2% | 12,8 M € | +57.6% | 8,1 M € | +2.9% | 7,9 M € | |
| Staff | 182 | 185,7 | 180,9 | 185,3 | 189,3 | 188,4 | 191,5 | 185,7 | 186 | 188,6 | 183,4 | 181,2 | 173,4 | 148,6 | 145,9 | 141,9 | 139 | 134,3 | 126,9 | |||||||||||||||||||
Non-profit organization · Zonhoven · incorporated on 04/07/1923 · 182,0 ETP
Non-profit organization profitable and well capitalised. Cash position rising (+755.4%).
Solid counterparty for a standard engagement.
CHRISTELIJKE WOON- EN ZORGCENTRA is a Non-profit organization incorporated in 1923. Its main activity is: Residential nursing care activities. Its registered office is in Zonhoven. It employs on average 182,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette